Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 2102

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : February | Volume : 17 | Issue : 2 | Page : AC06 - AC11 Full Version

Molecular Characterisation of X-ray Cross-complementing Group 1 (XRCC1) Gene and Risk Factors in Senile Cataract Patients attending a Tertiary Care Hospital, Uttar Pradesh, India


Published: February 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/60420.17454
Mohammad Ashraf Khan, Vandana Tewari, Ruchika Agrawal, Medha Das, R Sujatha, Nashra Afaq

1. Research Scholar, Department of Anatomy, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. 2. Professor, Department of Anatomy, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. 3. Professor, Department of Ophthalmology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. 4. Professor, Department of Anatomy, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. 5. Professor, Department of Microbiology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. 6. Research Assistant, Department of Microbiology and Central Research Lab, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India.

Correspondence Address :
Dr. Mohammad Ashraf Khan,
Flat No. 2, Type 4 Building, LBRKM Government Medical College Campus, Dimrapal, Jagdalpur, Chhattisgarh, India.
E-mail: drashraf4u@gmail.com

Abstract

Introduction: Cataract arises because of aging of the crystalline lens of the eye which prevents clear vision. X-ray Cross-complementing Group 1 (XRCC1) is a Deoxyribonucleic Acid (DNA) repair protein which is involved in Single-Strand Breaks (SSBs) and Base Excision Repair (BER) pathway which is responsible for the efficient repair of DNA damage is mainly responsible for cataract in patients.

Aim: To study the prevalence, risk factors and the molecular characterisation with its special association to XRCC1 gene in senile cataract patients.

Materials and Methods: This was a cross-sectional study carried out in the Department of Anatomy and Ophthalmology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India, from April 2021 to April 2022. A total of 500 clinical patients were included in which 250 patients were confirmed as cataract positive patients. Venous blood of 5 mL was collected in Ethylene diamine tetra-acetic acid tubes. The DNA extraction for the detection of XRCC1gene was done using Qiagen DNA extraction kit as per manufactures guidelines, which was further confirmed by Reverse Transcription-Polymerase Chain Reaction (RT-PCR).

Results: A total of 500 clinically suspected patients were included in which 250 cases were confirmed as cataract positive patients. The ratio of females was more (n=130, 52%) compared to males (n=120, 48%) with the mean age for females with 57.6% and for males with 61.13%. Hypertension (n=173, 69.2%) was the most common disease associated with the cataract patients. The ratio of males were more (n=91, 75.8%) compared to females (n=82, 63.07%). The mean age of males was 64.40 years and that of females were 62.45 years. The other co-morbidity included diabetes (48.8%), in which males constituted 67 (55.83%) participants compared to the females with 55 (42.3%) participants. The presence of XRCC1 gene was detected in all cataract positive patients, which was also confirmed by RT-PCR.

Conclusion: The polymorphisms of DNA repair genes decreased their ability to repair DNA damage, leaving human body a greatly increased susceptibility to cancer or age-related diseases. The association of XRCC1 gene with age-related cataract susceptibility observed in the present study supports the view that XRCC1 gene plays an important role in susceptibility to age-related cataract, so early screening and its molecular profiling will help the clinician in the early diagnosis as well as early treatment.

Keywords

Aging, Crystalline lens, Molecular profiling, Repair protein, Single-strand breaks

Cataract is an opacification of the lens that obscures the passage of light to the retina of the eye, causing low vision. It is the main cause of reversible blindness with an estimated 95 million people affected worldwide. Cataract has been documented to be the most significant cause of bilateral blindness in India where vision <20/200 in the better eye on presentation is defined as blindness (1).

The prevalence of cataract is higher in females than males in the developed and developing countries. In developing countries, cataract occurs at an earlier age (2). Population-based studies have reported high prevalence rates of cataract in India compared with western populations (3),(4). Hypertension is linked to development of cataract and people with severe hypertension have a higher risk of cataract (5). Lee H et al., observed that risk factors like diabetes mellitus, high myopia, occupational exposure to metal work, atopic dermatitis and smoking were responsible for presenile cataract (6). As the age increases, the lenses of the eyes become less flexible, less transparent and thicker. Due to diabetes, high blood glucose levels over time can lead to structural changes in the lens of the eye that can accelerate the development of cataracts. There is also the association of cataract in patients with Diabetes Mellitus (DM) with age and duration of DM (7).

Deoxyribonucleic Acid (DNA) repair enzymes continuously monitor chromosomes to correct damaged nucleotide residues generated by exposure to carcinogens and cytotoxic compounds (8). Studies have confirmed that polymorphisms of DNA repair genes decreased their ability to repair DNA damage, leaving human body a greatly increased susceptibility to cancer or age-related diseases [9,10]. Base Excision Repair (BER) is one of the most crucial DNA repair pathways. As the key enzymes of the BER pathway, association between 8-oxoguanine Glycosylase-1 (OGG1), AP Endonuclease-1 (APE1) and X-ray Cross-complementing Group 1 (XRCC1) genes polymorphisms and Age-related Macular Degeneration (AMD), pterygium and onset primary open-angle glaucoma have been studied frequently and XRCC1 marks as a good biomarker of DNA damage (11),(12). In addition to ophthalmic disorders, malignancies, diabetes and neurological disorders such as Huntington’s disease are also focuses of Single-nucleotide Polymorphism (SNP) researches (13),(14).

The proven role of XRCC1 gene plays a very important role in patients associating the risk of cataract, would help the study in understanding the DNA repair mechanism. Hence, the present study was aimed to investigate the prevalence, its risk factors and the presence of XRCC1 gene among senile cataract patients, as XRCC1 is a DNA repair gene that’s emerging as an essential element in the repair of both damaged bases and Single-Strand Breaks (SSBs) marks as an important biomarker of DNA damage. Moreover, the present study will be helpful in understanding the precise mechanisms by which genetic polymorphisms of DNA repair genes influence the process of lens opacification.

Material and Methods

The present cross-sectional study carried out in the Department of Anatomy and Ophthalmology, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India, from April 2021 to April 2022. A total of 500 clinical patients were included. Ethical clearance was taken from the Institutional Ethical Committee (RMCH/Pediatrics/2021/09).

Inclusion criteria: Patients affected with cataract and those who were ready to give their consent were included in the study.

Exclusion criteria: Patients suffering from any immunocompromised disease, patients with type1 diabetes mellitus, those with any thyroid disorder, tuberculosis and cancer, pregnant and lactating females were excluded from the study.

Study Procedure

The demographic details and clinical history along with the relevant clinical investigations like visual acuity test slit-lamp examination, retinal exam and applanation tonometry were recorded. A 5 mL of venous blood was collected in Ethylenediamine Tetraacetic (EDTA) acid tubes. The DNA extraction for the detection of XRCC1gene was done using Qiagen DNA Extraction Kit as per manufactures guidelines, which was further confirmed by Reverse Transcription-Polymerase Chain Reaction (RT-PCR).

The presence of XRCC1 gene was detected using Rotor-Gene Q Software 2.3.1.49 by RT-PCR, and found that XRCC1, a DNA repair protein involved in SSBs and BER pathway, have been reported to be responsible for the efficient repair of DNA damage caused by active oxygen, ionisation and alkylating agents is mainly responsible for cataract in patients.

Genotypic method: The molecular detection of DNA extraction was done to detect the presence of XRCC1 gene in clinically positive cataract positive patients with the history like personal and demographic data, reason for visit or presenting complaint, past eye history, general medical history, family eye history and allergy history along with examinations like slit-lamp examination and applanation tonometry test were recorded.

DNA extraction: For the detection of XRCC1 gene, chromosomal DNA from the clinical positive cataract patients was done. DNA extraction was carried out using a commercial available the DNA extraction kit (Qiagen DNA Extraction Kit) as indicated by manufacturer’s instructions.

Polymerase chain reaction cycling: The amplified DNA was further confirmed by RT-PCR. Primers used for amplification of XRCC1 gene (Table/Fig 1) (15).

Polymerase Chain Reaction (PCR) and its cycling conditions: After the DNA extraction, the RT-PCR was done. The sequences of the primers used in RT-PCR for detection of XRCC1 gene and its molecular weight are mentioned in the (Table/Fig 2),(Table/Fig 3).

The first step in a real-time PCR reaction was the conversion of RNA to complementary DNA (cDNA) known as reverse transcription. The next step uses fluorescent reporters and a PCR reaction to amplify and detect specific genes. The annealing allows the primers to connect to a specific spot on the single-stranded template DNA and extension step (20 seconds to one minute at 72°C), by which the DNA polymerase extends the primer sequences from the 3’ of each primer to the end of the amplicon along with the suitable temperature and time, the time and temperature was adjusted according to the test. The SYBR Green dye emits its fluorescent signal simply by binding to the double-stranded DNA in solution (Table/Fig 4).

In the experimental set-up, all the required entries were entered in the RT-PCR like name of the run, the run time wherein accordingly to the finish run, operator method, the software name of the version and the serial number of the machine along with it the melt information for threshold was entered (Table/Fig 5).

Master mix prepration for XRCC 1 gene:

Evagreen master mix=10 uL
Forward primer=0.25 uL
Reverse primer=0.25 uL
Nuclease free water=4.50 uL
DNA template=5.00 uL
Total volume=20.00 uL

The above master mix, sometimes known as super mix or ready mix, is a batch mixture of PCR reagents at optimal concentrations that can be prepared and divided among many PCR tubes or 96-well PCR plates. The master mix usually includes DNA polymerase, Deoxynucleoside Triphosphates (dNTPs), Magnesium chloride (MgCl2) and buffer. The quantity of the primers and master mix was already provided in the kit.

Primers was obtained from ‘Saha gene’ and was reconstituted with sterile double distilled water based on the manufacturer’s instruction.

Statistical Analysis

Descriptive data analysis was done. The data was analysed by descriptive statistics.

Results

A total of 500 clinically suspected patients with cataract were included, in which 250 were confirmed to have cataract. There were more females (n=130) than males (n=120). The mean age of the population was 59.37 years. Hypertension was the most common (n=173, 69.2%) disease associated with the cataract patients. The number of males were more (n=91, 75.8%) compared to females (n=82, 63.07%). The mean age of males was 64.40 years and that of females was 62.45 years. The other co-morbidity included diabetes (48.8%), in which males constituted 67 (55.83%) participants compared to the females with 55 (42.3%) participants (Table/Fig 6). The presence of XRCC1 gene was detected in all cataract positive patients, which was also confirmed by RT-PCR. From the (Table/Fig 7),(Table/Fig 8),(Table/Fig 9),(Table/Fig 10),(Table/Fig 11),(Table/Fig 12),(Table/Fig 13),(Table/Fig 14),(Table/Fig 15),(Table/Fig 16),(Table/Fig 17),(Table/Fig 18),(Table/Fig 19),(Table/Fig 20),(Table/Fig 21) Indicates the presence of XRCC1 gene along with its melting point and Cycle Threshold (CT) in sample 1 to 17, which were confirmed by RT-PCR. [Table/Fig-13,14] indicates the quantitation information for the run sample. The CT value more than 35 was considered negative for the XRCC1 gene.

Discussion

Cataract is one of the most common causes of visual impairment in the world cause of nearly half of the blind population. It is a vision impairing disease that occurs due to aging, and mainly affects elderly patients or people above the age of 50. This condition causes clouding in the eye lens or thickening of the lens, which leads to decrease in vision that gradually worsens with time. Senile cataract has high probability of causing partial or total blindness if left untreated. In fact, it is one of the leading causes of blindness worldwide (16). The oxidative stress is supposed to be an important factor in the development of Age-related Macular Degeneration (AMD). XRCC1 gene locates on chromosome 19q13.2. The protein encoded by this gene is involved in the efficient repair of DNA SSBs (17). Genome instability caused by the great variety of DNA damaging agents would be an overwhelming problem for cells and organisms if it were not for DNA repair.

Deoxyribose nucleic acid repair enzyme X-ray repair cross-complementing-1 plays an important role in continuously monitoring chromosomes to correct damaged nucleotide residues generated by exposure to carcinogens and cytotoxic compounds. Studies have confirmed that polymorphisms of DNA repair genes decreased their ability to repair DNA damage, leaving human body a greatly increased susceptibility to cancer or age-related diseases (17). BER is of great importance in DNA excision repair pathway as XRCC1 the key enzymes in BER pathway (18).

Hypertension is linked to senile cataract development and people with severe hypertension have a higher risk of cataract (5). The oxidative stress which is associated with diabetes mellitus, might play an important role in the initiation and progression of diabetic complications, it has been suggested that free oxygen radical trigger cataract, kind of the degenerative manifestations of diabetes mellitus (19).

The human XRCC1, a DNA repair protein, in human is encoded by XRCC1 gene. It is a most well-known DNA repair protein, complexing with atleast three different enzymes, Poly-Adipose Diphosphate (ADP)-ribose Polymerase (PARP), DNA ligase III, and DNA polymerase β. The human XRCC1 gene (Gene ID 37414; OMIM 21171001 and 21174504) is 33 kb long and located on chromosome 19q13.2-13.3, consists of 17 exons, and encodes a 2.2 kb transcript, which corresponds to a putative protein of 633 amino acids.

Wherever, DNA repair complexes with DNA ligase III XRCC1 is also involved. Due to the exposure to ionising radiation and alkylating agents, DNA SSBs occur and these can be efficiently repaired by XRCC1. XRCC1 protein participates in the BER pathway due to interaction with DNA ligase III, polymerase beta and poly (ADP-ribose) polymerase (20).

It also plays a role in DNA processing during meiogenesis and recombination in germ cells. The XRCC1 protein acts as a scaffolding protein, so that it interacts with multiple repair enzymes. Due to scaffolding, repair enzymes carry out their enzymatic steps in repairing DNA. XRCC1 has a crucial role in SSB repair, BER and nucleotide excision repair.

In the present study, the presence of XRCC1 gene as a DNA repair gene was detected. This finding was parallel to many other studies where XRCC1 gene was detected in senile cataract patients (21),(22). The DNA damage of lens epithelial cells may be the primary cause of lens opacity. DNA repair efficacy affected by genetic defect, which is associated with Age-related Cataract (ARC) (23).

Evidence has shown that XRCC1 is implicated in SSBs and the BER pathway and has been reported to be responsible for the efficient repair of DNA damage caused by ionisation, oxygen and alkylating agents (24). Several polymorphisms were investigated in the XRCC1 gene with the coding polymorphism resulting in amino acid substitutions detected at codon 399 (Arg-Gln) receiving the most attention (25). The XRCC1 may have a strong association with the ability to repair Deoxyribonucleic Acid (DNA); they could potentially influence many age-related diseases including cancers, atherosclerosis, and eye problems such as glaucoma, Age-related Macular Degeneration (AMD), and pterygium (26). More importantly, genetic polymorphisms of XRCC1 have also been frequently documented in many human age-related cataract cases (27). In this regard, it states that the genetic polymorphisms of XRCC1 may be related to the development and progression of age-related cataract.

An association between the development of lens opacities and oxidative stress or Ultraviolet (UV) light-induced DNA damage in the lens epithelium has been reported, and the effects of DNA repair in lens epithelial cells have also been proved (28). Specifically, oxidative stress is involved in cataractogenesis, in this regard, the role of antioxidants could be considered as a potential cataract preventive agent. A potential explanation is that the active oxygen radicals damage the lens epithelial cells, and large conformational changes in proteins may be found as protein-protein cross-links, which causes a corresponding increase in concentration (29). The XRCC1 genetic polymorphisms may be useful for identifying age-related cataract patients at an early stage (30).

It is noteworthy that XRCC1 was demonstrated to be implicated in SSBs and the BER pathway, which is one of the most important pathways involved in the repair of oxidative and UV-related DNA damage (31),(32). However, the variants of XRCC1 may contribute to disturbing single-base damage repair and single-strand DNA breaks resulting from endogenous oxidative radiation and inflammatory DNA damaging processes (33). Although the pathophysiology of cataract is still not fully understood, as a multifactorial disease caused by interaction between genetic and environmental factors, epidemiological investigations prompt many risk factors such as diabetes, gender, sunlight or ultraviolet radiation, smoking and nutritional deficiencies, etc., may relate to cataract formation. It has been well accepted that oxidative stress plays a critical role in the pathogenesis of senile cataract. The association of XRCC1 plays a critical role in the elevated susceptibility to age-related cataracts revealing that this mutation was also regarded as one of the potential mechanisms increasing the risk of age-related cataracts.

Limitation(s)

The present study was limited by its small sample size. More insights about the aetiology and modifiable risk factors for cataract would have been generated by a large sample size. Also, the present study was self supported so there was a lack of financial help because of which the other genes responsible for DNA repair damage could not be targeted.

Conclusion

The XRCC1 protein participates in the BER pathway due to interaction with DNA ligase III, polymerase beta and poly (ADP-ribose) polymerase. XRCC1 has a crucial role in SSB repair, BER and nucleotide excision repair. The association of XRCC1 polymorphisms with age-related cataract susceptibility observed in the present meta-analyses supports the view that XRCC1 plays an important role in susceptibility to age-related cataract. Thus, early screening and detection of XRCC1 genetic polymorphisms may be useful for identifying age-related cataract patients at an early stage.

Acknowledgement

The authors are thankful to the Principal and Director of the Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India, for providing facilities and permission to perform this original work at this Institute.

References

1.
Neuhann I, Neuhann L, Neuhann T. Die senile Katarakt (Age-related Cataract). Klin Monbl Augenheilkd. 2022;239:615-33. [crossref] [PubMed]
2.
Song P, Wang H, Theodoratou E, Chan KY, Rudan I. The national and subnational prevalence of cataract and cataract blindness in China: A systematic review and meta-analysis. Journal of Global Health. 2018;8(1):010804. [crossref] [PubMed]
3.
Hugosson M, Ekström C. Prevalence and risk factors for age-related cataract in Sweden. Upsala Journal of Medical Sciences. 2020;125(4):311-15. [crossref] [PubMed]
4.
Singh S, Pardhan S, Kulothungan V, Swaminathan G, Ravichandran JS, Ganesan S, et al. The prevalence and risk factors for cataract in rural and urban India. Indian Journal of Ophthalmology. 2019;67(4):477. [crossref] [PubMed]
5.
Kumar CM, Seet E, Eke T, Joshi GP. Hypertension and cataract surgery under loco-regional anaesthesia: Not to be ignored? British Journal of Anaesthesia. 2017;119(5):855-59. [crossref] [PubMed]
6.
Lee H, Jin Y, Roh M, Tsacogianis TN, Park S, Choi NK, et al. Risk of cataract surgery and age-related macular degeneration after initiation of Denosumab vs Zoledronic acid for osteoporosis: A multi-database cohort study. Drugs & Aging. 2020;6:1-0. [crossref] [PubMed]
7.
Machan Carolyn M, Hrynchak Patricia K, Irving Elizabeth L. Age-related cataract is associated with type 2 diabetes and statin use. Optometry and Vision Science. 2012;89(8):1165-71. [crossref] [PubMed]
8.
Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284-89. [crossref] [PubMed]
9.
Karahalil B, Bohr VA, Wilson DM 3 rd. Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum Exp Toxicol. 2012;31:981-1005. [crossref] [PubMed]
10.
Dizdaroglu M. Oxidatively induced DNA damage: Mechanisms, repair and disease. Cancer Lett. 2012;327:26-47. [crossref] [PubMed]
11.
Chiang CC, Tsai YY, Bau DT, Cheng YW, Tseng SH, Wang RF, et al. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD. Mol Vis. 2010;16:698-704.
12.
Szaflik JP, Cuchra M, Przybylowska-Sygut K, Dziki L, Kurowska AK, Gacek M, et al. Association of the 399Arg/Gln XRCC1, the 194 Arg/Trp XRCC1, the 326Ser/ Cys OGG1, and the 324Gln/His MUTYH gene polymorphisms with clinical parameters and the risk for development of primary open-angle glaucoma. Mutat Res. 2013;753:12-22. [crossref] [PubMed]
13.
Peng Y, Li Z, Zhang S, Xiong Y, Cun Y, Qian C, et al. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. Int J Cancer. 2014;135:2687-96. [crossref] [PubMed]
14.
Berger F, Vaslin L, Belin L, Asselain B, Forlani S, Humbert S, et al. The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntingtondisease. Mutat Res. 2013;755:115-19. [crossref] [PubMed]
15.
Wang C, Lai Q, Zhang S, Hu J. Senile cataract and genetic polymorphisms of APE1, XRCC1 and OGG1. International Journal of Clinical and Experimental Pathology. 2015;8(12):16036.
16.
Klein BE, Klein R, Lee KE, Danforth LG. Drug use and five year incidence of age- related cataracts. The Beaver Dam Eye Study Ophthalmology. 2001;108:1670-74. [crossref] [PubMed]
17.
Dianov GL, Sleeth KM, Dianova II, Allinson SL. Repair of abasic sites in DNA. Mutat Res. 2003;531:157-63. [crossref] [PubMed]
18.
Langie SA, Sabine KP, Tomaszewski B, Vasilaki A, Maas L, Moonen E, et al. Redox and epigenetic regulation of the APE1 gene in the hippocampus of piglets: The effect of early life exposures. DNA Repair (Amst). 2014;18:52-62. [crossref] [PubMed]
19.
Özmen B, Özmen D, Erkin E, Güner I ?, Habif S, Bayindir O. Lens superoxide dismutase and catalase activities in diabetic cataract. Clinical Biochemistry. 2002;35(1):69-72. [crossref] [PubMed]
20.
Prasad M, Malhotra S, Kalaivani M, Vashist P, Gupta SK. Gender differences in blindness, cataract blindness and cataract surgical coverage in India: A systematic review and meta-analysis. Br J Ophthalmol. 2020;104(2):220-24. [crossref] [PubMed]
21.
Unal M, Güven M, Batar B, Ozaydin A, Sarici A, Devranog? lu K. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp Eye Res. 2007;85(3):328-34. [crossref] [PubMed]
22.
Liang J, Jiang T, Yao RY, Liu ZM, Lv HY, Qi WW. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Cancer Chemother Pharmacol. 2010;66(3):493-500. [PMID:19960344]. [crossref] [PubMed]
23.
Xu Z, Liang G, Zhang Y, Ma L, Zhu S, Zhao X. The relationship of DNA repair gene XPD, XRCC1, OGG1, APE1, and WRN polymorphism with the risk of age-related cataract in Hani people from Mojiang region in Yunnan. Int J Clin Exp Med. 2016;9(5):8706-12.
24.
Mutamba JT, Svilar D, Prasongtanakij S, Wang XH, Lin YC, Dedon PC, et al. XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst). 2011;10:1282-93. [crossref] [PubMed]
25.
Qi Y, Cui L, Song Y, Li N. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: A meta-analysis. Mol Biol Rep. 2014;41:879-87. [crossref] [PubMed]
26.
Zhang Y, Zhang L, Song Z, Sun DL, Liu HR, Fu SB, et al. Genetic polymorphisms in DNA repair genes OGG1, APE1, XRCC1, and XPD and the risk of age-related cataract. Ophthalmology. 2012;119:900-06. [crossref] [PubMed]
27.
Padma G, Mamata M, Reddy KR, Padma T. Polymorphisms in two DNA repair genes (XPD and XRCC1)-association with age related cataracts. Mol Vis. 2011;17:127-33.
28.
Varma SD, Kovtun S, Hegde KR. Role of ultraviolet irradiation and oxidative stress in cataract formation-medical prevention by nutritional antioxidants and metabolic agonists. Eye Contact Lens. 2011;37:233-45. [crossref] [PubMed]
29.
Berthoud VM, Beyer EC. Oxidative stress, lens gap junctions, and cataracts. Antioxid Redox Signal. 2009;11:339-53. [crossref] [PubMed]
30.
Cui YH, Jing CX, Pan HW. Association of blood antioxidants and vitamins with risk of age-related cataract: A meta-analysis of observational studies. Am J Clin Nutr. 2013;98(3):778-86. [crossref] [PubMed]
31.
Chi XX, Liu YY, Shi SN, Cong Z, Liang YQ, Zhang HJ. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: A meta-analysis. 2015;21:335-46.
32.
Kulkarni A, Wilson DM. The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet. 2008;82:539-66. [crossref] [PubMed]
33.
Luo YF, Wang BB, Zhou Z, Ding XC, Hu SS, Zhou GK, et al. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related cataract development in Han Chinese. Curr Eye Res. 2011;36:632-36.[crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/60420.17454

Date of Submission: Sep 28, 2022
Date of Peer Review: Nov, 10, 2022
Date of Acceptance: Jan 01, 2023
Date of Publishing: Feb 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Oct 01, 2022
• Manual Googling: Dec 06, 2022
• iThenticate Software: Dec 26, 2022 (19%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com